Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.29M | 48.10M | 48.54M | 49.03M | 50.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.29M | 48.10M | 48.54M | 49.03M | 50.45M |
| Cost of Revenue | 18.21M | 18.74M | 19.22M | 18.68M | 18.32M |
| Gross Profit | 29.08M | 29.36M | 29.33M | 30.35M | 32.14M |
| SG&A Expenses | 39.87M | 43.13M | 45.53M | 47.29M | 47.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.57M | 66.95M | 70.12M | 71.61M | 71.41M |
| Operating Income | -15.28M | -18.85M | -21.57M | -22.58M | -20.96M |
| Income Before Tax | -19.89M | -23.31M | -28.27M | -28.60M | -23.02M |
| Income Tax Expenses | 248.00K | 252.00K | 250.00K | -128.00K | -112.00K |
| Earnings from Continuing Operations | -20.14 | -23.56 | -28.52 | -28.48 | -22.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 104.00K | 96.00K | 82.00K | 107.00K | 102.00K |
| Net Income | -20.04M | -23.46M | -28.44M | -28.37M | -22.81M |
| EBIT | -15.28M | -18.85M | -21.57M | -22.58M | -20.96M |
| EBITDA | -14.70M | -18.25M | -20.96M | -21.92M | -20.31M |
| EPS Basic | -0.55 | -0.66 | -0.82 | -0.82 | -0.66 |
| Normalized Basic EPS | -0.34 | -0.41 | -0.45 | -0.46 | -0.41 |
| EPS Diluted | -0.55 | -0.66 | -0.82 | -0.82 | -0.66 |
| Normalized Diluted EPS | -0.34 | -0.41 | -0.45 | -0.46 | -0.41 |
| Average Basic Shares Outstanding | 148.23M | 142.15M | 138.58M | 138.57M | 138.53M |
| Average Diluted Shares Outstanding | 148.23M | 142.15M | 138.58M | 138.57M | 138.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |